603P - A phase Ib study of the safety and efficacy of atezolizumab (atezo) + bevacizumab (bev) + cobimetinib (cobi) in patients (pts) with metastatic colorectal cancer (mCRC) von Bendell, J., Lieu, C., Raghav, K.P.S., Argilés, G., Cubillo, A., Qu, X., Yan, Y., Merchant, M., Zeuner, H., Gallo, J.D., Segal, N.H.

Volltext

A phase Ib study of the safety and efficacy of atezolizumab (atezo) + bevacizumab (bev) + cobimetinib (cobi) in patients (pts) with metastatic colorectal cancer (mCRC) von Bendell, J., Lieu, C., Raghav, K.P.S., Argilés, G., Cubillo, A., Qu, X., Yan, Y., Merchant, M., Zeuner, H., Gallo, J.D., Segal, N.H.

Volltext

448PD - Genomic profiling of three pathways through molecular profiling-based assignment of cancer therapy (NCI- MPACT) von Chen, A., Kummar, S., Khan, S.S., Moore, N., Rubinstein, L., Coyne, G O’Sullivan, Zhao, Y., Palmisano, A., Williams, P., Datta, V., Sims, D., Karlovich, C., Lih, C.-J., Raghav, K.P.S., Meric-Bernstam, F., Leong, S., Waqar, S., Takebe, N., Sharon, E., Doroshow, J.

Volltext

Genomic profiling of three pathways through molecular profiling-based assignment of cancer therapy (NCI- MPACT) von Chen, A., Kummar, S., Khan, S.S., Moore, N., Rubinstein, L., Coyne, G O’Sullivan, Zhao, Y., Palmisano, A., Williams, P., Datta, V., Sims, D., Karlovich, C., Lih, C.-J., Raghav, K.P.S., Meric-Bernstam, F., Leong, S., Waqar, S., Takebe, N., Sharon, E., Doroshow, J.

Volltext

Supplementary Material for: Definitive liver radiotherapy for intrahepatic cholangiocarcinoma with extrahepatic metastases von B., De, R., Upadhyay, K., Liao, T., Kumala, C., Shi, G., Dodoo, J., AbiJaoude, K.L., Corrigan, G.S., Manzar, K.E., Marqueen, V., Bernard, S.S., Lee, K.P.S., Raghav, J.-N., Vauthey, C.-W., Tzeng, H.S., TranCao, G., Lee, J., Wo, T.S., Hong, C.H., Crane, B.D., Minsky, G.L., Smith, E.B., Holliday, C.M., Taniguchi, A.C., Koong, P., Das, M., Javle, E.B., Ludmir, E., Koay

Volltext bestellen